1394P Alkaline phosphatase (ALP) decline and pain response as markers for overall survival (OS) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra) in the REASSURE study

Autor: O'Sullivan, J., Heinrich, D., Castro Marcos, E., George, S., Song, D.Y., Dizdarevic, S., Baldari, S., Essler, M., de Jong, I.J., Lastoria, S., Hammerer, P.G., Tombal, B., James, N.D., Verholen, F., Meltzer, J., Sandström, P., Sartor, O.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S1181-S1181
Databáze: ScienceDirect